Glen Eagle Advisors’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-100
Closed -$8.47K 1155
2024
Q1
$8.47K Hold
100
﹤0.01% 690
2023
Q4
$7.49K Hold
100
﹤0.01% 679
2023
Q3
$6.92K Hold
100
﹤0.01% 682
2023
Q2
$7.26K Hold
100
﹤0.01% 683
2023
Q1
$7.19K Hold
100
﹤0.01% 673
2022
Q4
$7.46K Hold
100
﹤0.01% 656
2022
Q3
$6.55K Hold
100
﹤0.01% 659
2022
Q2
$7.05K Hold
100
﹤0.01% 674
2022
Q1
$9.2K Hold
100
﹤0.01% 639
2021
Q4
$10.1K Hold
100
﹤0.01% 620
2021
Q3
$9.72K Hold
100
﹤0.01% 703
2021
Q2
$10.3K Hold
100
﹤0.01% 686
2021
Q1
$8.89K Hold
100
﹤0.01% 684
2020
Q4
$9.41K Hold
100
﹤0.01% 650
2020
Q3
$8.66K Buy
+100
New +$8.33K ﹤0.01% 621
2020
Q1
Sell
-150
Closed -$16.4K 871
2019
Q4
$16.4K Buy
+150
New +$15.2K 0.01% 497

Other funds holding CRI

Glen Eagle Advisors's CRI Position: Q2 2024 in Review

Glen Eagle Advisors sold out of Carter's (CRI) in Q2 2024, closing a stake of 100 shares — an estimated $8.47K sold.

Glen Eagle Advisors first reported a position in CRI in Q4 2019 and held it in 16 quarters. The position peaked at $16.4K in Q4 2019. 329 funds tracked by Wall St. Rank hold CRI as of Q2 2024.

  • Glen Eagle Advisors reported no remaining Carter's position as of Q2 2024 after selling out during the quarter.
  • Glen Eagle Advisors sold 100 Carter's shares in Q2 2024, an estimated $8.47K.
  • Glen Eagle Advisors first reported a position in Carter's in Q4 2019 and held it in 16 quarters.
  • Glen Eagle Advisors's Carter's position peaked at $16.4K in Q4 2019.
  • 329 funds tracked by Wall St. Rank held Carter's as of Q2 2024.

Based on Glen Eagle Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.